DiaSorin S.p.A.

Milan Stock Exchange:DIA.MI

Location

Market Cap

USD 5.86 B

Share Price

USD 108.81

Avg Daily Volume

152,641

Change (1 day)

0.09%

Change (1 year)

7.61%

Change (YTD)

5.03%

DiaSorin S.p.A. Enterprise Value to EBITDA (EV/EBITDA) on June 23, 2025: 15.87

DiaSorin S.p.A. Enterprise Value to EBITDA (EV/EBITDA) is 15.87 on June 23, 2025, a -10.79% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • DiaSorin S.p.A. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 20.38 on June 23, 2025, which is 28.47% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • DiaSorin S.p.A. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 14.45 on June 23, 2025, which is -8.96% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • DiaSorin S.p.A. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 17.91.
Key data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization
Market news
Loading...
Milan Stock Exchange: DIA.MI

DiaSorin S.p.A.

CEO Mr. Carlo Rosa
IPO Date July 19, 2007
Location Italy
Headquarters Via Crescentino snc
Employees 3,249
Sector 🏥 Health Care
Industries
Description

DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Similar companies

RO.SW

Roche Holding AG

USD 339.66

0.85%

ABT

Abbott Laboratories

USD 133.26

0.20%

TMO

Thermo Fisher Scientific Inc.

USD 400.21

0.59%

BSX

Boston Scientific Corporation

USD 102.36

1.05%

SHL.DE

Siemens Healthineers AG

USD 53.89

1.17%

BDX

Becton, Dickinson and Company

USD 169.72

0.77%

A

Agilent Technologies, Inc.

USD 116.13

0.49%

GEHC

GE HealthCare Technologies Inc.

USD 71.16

-0.17%

NTRA

Natera, Inc.

USD 170.37

-0.87%

LH

Laboratory Corporation of America Holdings

USD 261.04

-0.32%

BIM.PA

bioMérieux S.A.

USD 140.07

1.06%

BAX

Baxter International Inc.

USD 29.99

0.00%

RVTY

Revvity, Inc.

USD 94.95

-0.04%

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.75

0.99%

QGEN

Qiagen N.V.

USD 46.71

-0.11%

EXAS

Exact Sciences Corporation

USD 52.54

-0.91%

CTEC.L

ConvaTec Group Plc

USD 3.92

2.96%

GMED

Globus Medical, Inc.

USD 57.81

-0.10%

BIO

Bio-Rad Laboratories, Inc.

USD 235.54

-0.51%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 7.94

-2.02%

BRKR

Bruker Corporation

USD 38.73

1.71%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.83

2.20%

LNTH

Lantheus Holdings, Inc.

USD 80.81

2.05%

688617.SS

APT Medical Inc.

USD 38.40

0.19%

TMDX

TransMedics Group, Inc.

USD 127.53

3.21%

INSP

Inspire Medical Systems, Inc.

USD 129.99

-0.70%

603658.SS

Autobio Diagnostics Co., Ltd.

USD 5.16

0.17%

LIVN

LivaNova PLC

USD 45.57

0.13%

VCYT

Veracyte, Inc.

USD 26.71

1.21%

VITR.ST

Vitrolife AB (publ)

USD 14.12

-0.35%

QDEL

QuidelOrtho Corporation

USD 27.65

-1.36%

0853.HK

MicroPort Scientific Corporation

USD 1.08

2.95%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 3.89

3.28%

688068.SS

Beijing Hotgen Biotech Co., Ltd.

USD 20.03

7.75%

688289.SS

Sansure Biotech Inc.

USD 2.83

-0.04%

INDGN.NS

Indegene Limited

USD 6.67

0.65%

ABBV

AbbVie Inc.

USD 183.76

-0.83%

NOVO-B.CO

Novo Nordisk A/S

USD 69.76

-4.86%

NOVN.SW

Novartis AG

USD 116.67

0.62%

AZN.L

AstraZeneca PLC

USD 140.89

0.81%

MRK

Merck & Co., Inc.

USD 80.16

1.39%

AMGN

Amgen Inc.

USD 272.44

-5.84%

DHR

Danaher Corporation

USD 196.34

-0.03%

PFE

Pfizer Inc.

USD 24.03

0.25%

GILD

Gilead Sciences, Inc.

USD 106.19

-2.13%

SAN.PA

Sanofi

USD 96.16

0.29%

VRTX

Vertex Pharmaceuticals Incorporated

USD 443.54

0.61%

MDT

Medtronic plc

USD 85.96

-0.44%

BMY

Bristol-Myers Squibb Company

USD 46.92

0.13%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 51.71

0.69%

StockViz Staff

June 25, 2025

Any question? Send us an email